“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: PP37 In vitro investigations of the effect of BCR-ABL tyrosine kinase inhibitors on endothelial cell viability

€3.03

SKU: product-article-15352 Category: General

Description

Description

PP37 In vitro investigations of the effect of BCR-ABL tyrosine kinase inhibitors on endothelial cell viability

Top

Article: PP37 In vitro investigations of the effect of BCR-ABL tyrosine kinase inhibitors on endothelial cell viability

Description

Related products

Article: Highlights in breast cancer

1 year subscription print edition of the Belgian Journal of Hematology (BJH)

Article: Highlights in respiratory oncology

Article: Highlights in genitourinary cancers